Matthew J. Wanat

Matthew J. Wanat

Auto-generated profile, based on publicly available information

Matthew J. Wanat

Department of Neuroscience, Developmental and Regenerative Biology, University of Texas at San Antonio, San Antonio, TX, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2010 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
SFSusan M Ferguson
Susan M Ferguson
DEDaniel Eskenazi
Daniel Eskenazi
MIMasago Ishikawa
Masago Ishikawa
MWMatthew J Wanat
Matthew J Wanat
PPPaul E M Phillips
Paul E M Phillips
JNJohn F Neumaier
John F Neumaier
The roles of striatopallidal (indirect) and striatonigral (direct) pathway neurons in regulating behavior is of great interest. Ferguson et al. selectively and transiently disrupt either one pathway or the other. They find that disrupting striatopallidal neuronal activity facilitated behavioral sensitization, whereas disrupting striatonigral neurons impaired its persistence. Dorsal striatum is important for the development of drug addiction; however, a precise understanding of the roles of striatopallidal (indirect) and striatonigral (direct) pathway neurons in regulating behaviors remains elusive. Using viral-mediated expression of an engineered G protein–coupled receptor (hM4D), we found that activation of hM4D receptors with clozapine-N-oxide (CNO) potently reduced striatal neuron excitability. When hM4D receptors were selectively expressed in either direct or indirect pathway neurons, CNO did not change acute locomotor responses to amphetamine, but did alter behavioral plasticity associated with repeated drug treatment. Specifically, transiently disrupting striatopallidal neuronal activity facilitated behavioral sensitization, whereas decreasing excitability of striatonigral neurons impaired its persistence. These findings suggest that acute drug effects can be parsed from the behavioral adaptations associated with repeated drug exposure and highlight the utility of this approach for deconstructing neuronal pathway contributions to behavior.

27 December 2009 in Nature Methods
Verified
Journal Article
Open access
PDF file
JCJeremy J Clark
Jeremy J Clark
SSStefan G Sandberg
Stefan G Sandberg
MWMatthew J Wanat
Matthew J Wanat
JGJerylin O Gan
Jerylin O Gan
EHEric A Horne
Eric A Horne
PPPaul E M Phillips
Paul E M Phillips
A chronically implanted biocompatible electrochemical microsensor allows long-term recording of subsecond dopamine dynamics in vivo. The microsensor can reliably detect behaviorally evoked dopamine release from dopamine neurons in the brain over a period of months in rats. Neurotransmission operates on a millisecond timescale but is changed by normal experience or neuropathology over days to months. Despite the importance of long-term neurotransmitter dynamics, no technique exists to track these changes in a subject from day to day over extended periods of time. Here we describe and characterize a microsensor that can detect the neurotransmitter dopamine with subsecond temporal resolution over months in vivo in rats and mice.

19 September 2012 in Nature
Verified
Journal Article
Open access
PDF file
JLJulia Lemos
Julia Lemos
MWMatthew J. Wanat
Matthew J. Wanat
JSJeffrey S Smith
Jeffrey S Smith
BRBeverly A. S. Reyes
Beverly A. S. Reyes
NHNick G. Hollon
Nick G. Hollon
PPPaul E. M. Phillips
Paul E. M. Phillips
The neuropeptide corticotropin-releasing factor (CRF) acts in the nucleus accumbens of mice to increase dopamine release through coactivation of CRF receptor 1 (CRFR1) and CRFR2, but exposure to severe stress results in loss of this regulation and a switch in the reaction to CRF from appetitive to aversive. Severe stress can exacerbate major depression, characterized by a shift from engagement with the environment to withdrawal. Paul Phillips and colleagues now identify a cellular mechanism involved in this shift. Using a mouse model, they find that corticotrophin-releasing factor (CRF), a stress-response-related neuropeptide, increases dopamine release in the nucleus accumbens, but that this regulation is lost after exposure to acute stress. Animals also show opposing responses to CRF application before and after stress. The authors suggest that severe stress switches the emotional response to stressful stimuli, and that this may be central to stress-induced depressive disorders. Stressors motivate an array of adaptive responses ranging from ‘fight or flight’ to an internal urgency signal facilitating long-term goals1. However, traumatic or chronic uncontrollable stress promotes the onset of major depressive disorder, in which acute stressors lose their motivational properties and are perceived as insurmountable impediments2. Consequently, stress-induced depression is a debilitating human condition characterized by an affective shift from engagement of the environment to withdrawal3. An emerging neurobiological substrate of depression and associated pathology is the nucleus accumbens, a region with the capacity to mediate a diverse range of stress responses by interfacing limbic, cognitive and motor circuitry4. Here we report that corticotropin-releasing factor (CRF), a neuropeptide released in response to acute stressors5 and other arousing environmental stimuli6, acts in the nucleus accumbens of naive mice to increase dopamine release through coactivation of the receptors CRFR1 and CRFR2. Remarkably, severe-stress exposure completely abolished this effect without recovery for at least 90 days. This loss of CRF’s capacity to regulate dopamine release in the nucleus accumbens is accompanied by a switch in the reaction to CRF from appetitive to aversive, indicating a diametric change in the emotional response to acute stressors. Thus, the current findings offer a biological substrate for the switch in affect which is central to stress-induced depressive disorders.

14 April 2008 in The Journal of Physiology
Verified
Journal Article
Closed access
MWM. J. Wanat
M. J. Wanat
FHF. W. Hopf
F. W. Hopf
GSG. D. Stuber
G. D. Stuber
PPP. E. M. Phillips
P. E. M. Phillips
ABA. Bonci
A. Bonci

15 September 2009
Verified
Book Chapter
Closed access
PDF file
IWIngo Willuhn
Ingo Willuhn
MWMatthew J. Wanat
Matthew J. Wanat
JCJeremy J. Clark
Jeremy J. Clark
PPPaul E. M. Phillips
Paul E. M. Phillips

1 May 2009 in Current Drug Abuse Reviews
Verified
Journal Article
Open access
PDF file
MWMatthew J. Wanat
Matthew J. Wanat
IWIngo Willuhn
Ingo Willuhn
JCJeremy J. Clark
Jeremy J. Clark
PPPaul E.M. Phillips
Paul E.M. Phillips
Although dopamine is implicated in the development of addiction, it is unclear how specific dopamine release patterns are involved with drug seeking. Addictive drugs increase tonic dopamine levels on the order of minutes, as well as phasic dopamine release events that occur on a subsecond time scale. Phasic dopamine release is associated with the initiation of goal-directed behaviors, and has been shown to promote drug seeking. Prior experience with addictive drugs modulates the synaptic and intrinsic properties of dopamine neurons, affects the pattern of dopamine neuron firing and release, and alters dopamine-dependent behaviors related to drug addiction. In this review, we synthesize the known drugdependent changes to the dopamine system along with the established functions of phasic dopamine release in order to provide a framework for conceptualizing the role of phasic dopamine release in drug addiction. Because drug addiction is commonly thought to involve changes in brain circuits important for natural reinforcement, we first present the role of phasic dopamine release in appetitive and goal-directed behaviors in the context of contemporary theories regarding the function of dopamine. Next, we discuss the known drug-induced changes to dopamine neurons and phasic release in both in vitro and in vivo preparations. Finally, we offer a simple model that chronic drug experience increases the contrast, or ‘signal to noise’, of phasic dopamine release to basal dopamine levels in response to drug-related stimuli, which could result in aberrant associations between cues and reinforcers that contribute to the development of addiction.